ReviewAdvances in immunology2001
Neutralizing antiviral antibody responses.
Review in Advances in immunology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Viral Vaccine Adjuvant Strategies for Shaping Durable Immunity Across the Human Lifespan.Vaccines · 2026Review
- Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain.Molecular biotechnology · 2025Article
- mRNA-LNP vaccine strategies: Effects of adjuvants on non-parenchymal liver cells and tolerance.Molecular therapy. Methods & clinical development · 2025Article
- Case Report: PositiveFrontiers in pediatrics · 2025Article
- Dynamics and durability of HIV-1 neutralization are determined by viral replication.Nature medicine · 2023Article
- Antiviral neutralizing antibodies: from in vitro to in vivo activity.Nature reviews. Immunology · 2023Review
- Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment.Microbial cell factories · 2021Review
- Effect of polymorphisms in porcine guanylate-binding proteins on host resistance to PRRSV infection in experimentally challenged pigs.Veterinary research · 2020Article
- Emerging Rodent-Borne Viral Zoonoses in Trento, Italy.EcoHealth · 2018Article
- Impact of Antigen Density on the Binding Mechanism of IgG Antibodies.Scientific reports · 2017Article
- Seroepidemiology of enterovirus D68 infection in China.Emerging microbes & infections · 2017Article
- Multiple Administrations of Viral Nanoparticles AlterACS biomaterials science & engineering · 2016Article
- Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection.Frontiers in immunology · 2016Article
- Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.Cell reports · 2015Article
- Influenza virus-specific neutralizing IgM antibodies persist for a lifetime.Clinical and vaccine immunology : CVI · 2014Article
- Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus.PLoS pathogens · 2013Article
- Article
- Immune mediators of rotavirus antigenemia clearance in mice.Journal of virology · 2011Article
- Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.Immunity · 2011Article
- Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.Cell host & microbe · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.